{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-040775","form_type":"8-K","ticker":"SIGA","cik":"0001010086","company_name":"SIGA TECHNOLOGIES INC","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.511664+00:00","generated_at":"2026-05-16T23:19:00.415445+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SIGA reports Q3 2025 net loss of $6.4M on $2.6M revenue, down from $1.3M income YoY","bullets":["Q3 2025 product sales fell to $0.9M from $8.9M YoY; total revenue $2.6M vs $10.0M.","Net loss of $6.4M ($0.09 diluted loss per share) vs net income of $1.3M ($0.02) in Q3 2024.","Nine-month 2025 product revenues $85.8M, net income $28.7M ($0.40 EPS) vs $53.5M and $13.5M ($0.19) in 2024.","Year-to-date $53M oral TPOXX and $26M IV TPOXX delivered to U.S. SNS; $6M oral to international customer.","Special dividend of $0.60/share paid May 2025; BARDA contract added $27M development funding in Q2."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-040775","json":"https://secwatch.observer/filing/0001140361-25-040775.json","markdown":"https://secwatch.observer/filing/0001140361-25-040775.md","text":"https://secwatch.observer/filing/0001140361-25-040775.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1010086/000114036125040775/0001140361-25-040775-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1010086/000114036125040775/ef20058429_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:19:00.415445+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}